Business
AstraZeneca COVID-19 vaccine faces regulatory hurdles as Novavax releases both ‘encouraging’ and ‘concerning’ results – ABC News
European regulatory bodies are questioning the lack of data supplied for the Oxford-AstraZeneca vaccine, recommending against its use for the elderly, as another…
Experts say the problems associated with “first-generation” COVID-19 vaccines are being exposed, as one European regulatory body questions the lack of data supplied for the Oxford-AstraZeneca vaccine and recommends against its use for the elderly.
Key points:
- European regulatory bodies are concerned over the lack of data for the elderly during trials of the Oxford-AstraZeneca vaccine
- The TGA, described as “the best regulator in the world” by the Health Minister, is expected to make a decision in…
Continue Reading
-
Business5 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General8 hours agoAlbanese beats drum on economy as trade clouds gather
-
General7 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General5 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner